

Kiora Pharmaceuticals also entered into a securities purchase agreement with certain institutional investors, pursuant to which Kiora agreed to issue and sell...
You can purchase shares of Kiora Pharmaceuticals (NASDAQ:KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Kiora Pharmaceuticals has a consensus price target of $10.00.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.7346 last updated November 20, 2026 at 4:00 PM EST.
There are no upcoming dividends for Kiora Pharmaceuticals.
Kiora Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa,...